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Abstract
The histological assessment of human tissue has emerged as the key challenge for detection and treatment of cancer. A
plethora of different data sources ranging from tissue microarray data to gene expression, proteomics or metabolomics
data provide a detailed overview of the health status of a patient. Medical doctors need to assess these information
sources and they rely on data driven automatic analysis tools. Methods for classification, grouping and segmentation
of heterogeneous data sources as well as regression of noisy dependencies and estimation of survival probabilities
enter the processing workflow of a pathology diagnosis system at various stages. This paper reports on state-of-the-art
of the design and effectiveness of computational pathology workflows and it discusses future research directions in
this emergent field of medical informatics and diagnostic machine learning.
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1. Computational Pathology: The systems view
Modern pathology studies of biopsy tissue encom-
pass multiple stainings of histological material, ge-
nomics and proteomics analyses as well as compara-
tive statistical analyses of patient data. Pathology lays
not only a scientific foundation for clinical medicine
but also serves as a bridge between the fundamental
sciences in natural science, medicine and patient care.
Therefore, it can be viewed as one of the key hubs for
translational research in the health and life sciences,
subsequently facilitating translational medicine. In par-
ticular, the abundance of heterogeneous data sources
with a substantial amount of randomness and noise
poses challenging problems for statistics and machine
learning. Automatic processing of this wealth of data
promises a standardized and hopefully more objective
diagnosis of the disease state of a patient than manual
inspection can provide today. An automatic computa-
tional pathology pipeline also enables the medical user
to quantitatively benchmark the processing pipeline and
to identify error sensitive processing steps which can
substantially degrade the final prediction of survival
times.
1.1. Definition
Computational Pathology as well as the medical dis-
cipline Pathology is a wide and diverse field which en-
compass scientific research as well as day-to-day work
in medical clinics. The following definition is an at-
tempt for a concise and practical description of this
novel field:
Computational Pathology investigates a com-
plete probabilistic treatment of scientific and
clinical workflows in general pathology, i.e.
it combines experimental design, statistical
pattern recognition and survival analysis to
an unified framework for answering scientific
and clinical questions in pathology.
Figure 1 depicts a schematic overview of the field and
the three major parts it consists of: data generation, im-
age analysis and medical statistics.
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Figure 1: Schematic overview of the workflow in computational pathology comprising of three major parts: (i) the covariate data X is acquired via
microscopy and the target data Y is generated in extensive labeling experiments; (ii) image analysis in terms of nuclei detection, cell segmentation
or texture classification provides detailed information about the tissue; (iii) medical statistics, i.e. survival regression and mixture of expert models
are used to investigate the clinical end point of interesting using data from the previous two parts. The aim is to build a complete probabilistic
workflow comprising all three parts. (The corresponding sections of the paper are noted in addition.)
2. Data: Tissue and Ground Truth
2.1. Clear Cell Renal Cell Carcinoma
Throughout this review we use Renal cell carcinoma
(RCC) as a disease case to design and optimize a com-
putational pathology framework because it exhibits a
number of properties which are highly relevant for com-
putational pathology.
Renal cell carcinoma figures as one of the ten most
frequent malignancies in the statistics of Western soci-
eties [1]. The prognosis of renal cancer is poor since
many patients suffer already from metastases at the
time of first diagnosis. The identification of biomark-
ers for prediction of prognosis (prognostic marker) or
response to therapy (predictive marker) is therefore of
utmost importance to improve patient prognosis [2].
Various prognostic markers have been suggested in the
past [3, 4], but estimates of conventional morphological
parameters still provide most valuable information for
therapeutical decisions.
Clear cell RCC (ccRCC) emerged as the most com-
mon subtype of renal cancer and it is composed of cells
with clear cytoplasm and typical vessel architecture.
ccRCC exhibits an architecturally diverse histological
structure, with solid, alveolar and acinar patterns. The
carcinomas typically contain a regular network of small
thin-walled blood vessels, a diagnostically helpful char-
acteristic of this tumor. Most ccRCC show areas with
hemorrhage or necrosis (Fig. 2d), whereas an inflam-
matory response is infrequently observed. Nuclei tend
to be round and uniform with finely granular and evenly
distributed chromatin. Depending upon the grade of
malignancy, nucleoli may be inconspicuous and small,
or large and prominent, with possibly very large nuclei
or bizarre nuclei occurring [1].
The prognosis for patients with RCC depends mainly
on the pathological stage and the grade of the tumor at
the time of surgery. Other prognostic parameters in-
clude proliferation rate of tumor cells and different gene
expression patterns. Tannapfel et al. [2] have shown that
cellular proliferation potentially serves as another mea-
sure for predicting biological aggressiveness and, there-
fore, for estimating the prognosis. Immunohistochem-
ical assessment of the MIB-1 (Ki-67) antigen indicates
that MIB-1 immunostaining (Fig. 2d) is an additional
prognostic parameter for patient outcome. TMAs were
highly representative of proliferation index and histo-
logical grade using bladder cancer tissue [5].
The TNM staging system specifies the local exten-
sion of the primary tumour (T), the involvement of re-
gional lymph nodes (N), and the presence of distant
metastases (M) as indicators of the disease state. [6]
focuses on reassessing the current TNM staging sys-
tem for RCC and concludes that outcome prediction for
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RCC remains controversial. Although many parame-
ters have been tested for prognostic significance, only a
few have achieved general acceptance in clinical prac-
tice. An especially interesting observation of [6] is that
multivariate Cox proportional hazards regression mod-
els including multiple clinical and pathologic covari-
ates were more accurate in predicting patient outcome
than the TNM staging system. On one hand this finding
demonstrates the substantial difficulty of the task and on
the other hand it is a motivation for research in compu-
tational pathology to develop robust machine learning
frameworks for reliable and objective prediction of dis-
ease progression.
2.2. Tissue Microarrays
The tissue microarray (TMA) technology signifi-
cantly accelerated studies seeking for associations be-
tween molecular changes and clinical endpoints [7]. In
this technology, 0.6mm tissue cylinders are extracted
from primary tumor material of hundreds of different
patients and these cylinders are subsequently embed-
ded into a recipient tissue block. Sections from such
array blocks can then be used for simultaneous in situ
analysis of hundreds or thousands of primary tumors on
DNA, RNA, and protein level (cf. 2). These results can
then be integrated with expression profile data which
is expected to enhance the diagnosis and prognosis of
ccRCC [8, 3, 9]. The high speed of arraying, the lack of
a significant damage to donor blocks, and the regular ar-
rangement of arrayed specimens substantially facilitates
automated analysis.
Although the production of tissue microarrays is an
almost routine task for most laboratories, the evaluation
of stained tissue microarray slides remains tedious hu-
man annotation work, it is time consuming and prone to
error. Furthermore, the significant intratumoral hetero-
geneity of RCC results in high interobserver variabil-
ity. The variable architecture of RCC also results in a
difficult assessment of prognostic parameters. Current
image analysis software requires extensive user inter-
action to properly identify cell populations, to select re-
gions of interest for scoring, to optimize analysis param-
eters and to organize the resulting raw data. Because of
these drawbacks in current software, pathologists typi-
cally collect tissue microarray data by manually assign-
ing a composite staining score for each spot - often dur-
ing multiple microscopy sessions over a period of days.
Such manual scoring can result in serious inconsisten-
cies between data collected during different microscopy
sessions. Manual scoring also introduces a significant
bottleneck that hinders the use of tissue microarrays in
high-throughput analysis.
Figure 3: Tablet PC labeling applications for (i) global staining esti-
mation (ii) nuclei detection and (iii) nuclei classification (from top to
bottom).
2.3. Analyzing Pathologists
To assess the inter and intra variability of patholo-
gists we designed three different labeling experiments
for the major tasks involved in TMA analysis. To fa-
cilitate the labeling process for trained pathologists we
developed software suite which allows the user to view
single TMA spots and which provides zooming and
scrolling capabilities. The expert can annotate the im-
age with vectorial data in SVG (support vector graph-
ics) format and he/she can mark cell nuclei, vessels and
other biological structures. In addition each structure
can be labeled with a class which is encoded by its color.
To increase usability and the adoption in hospitals we
specifically designed the software for tablet PC so that a
pathologist can perform all operations with a pen alone
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(a) (b) (c) (d) (e)
Figure 2: Tissue Microarray Analysis (TMA): Primary tissue samples are taken from a cancerous kidney (a). Then 0.6mm tissue cylinders are
extracted from the primary tumor material of different patients and arrayed in a recipient paraffin block (b). Slices of 0.6µm are cut off the paraffin
block and are immunohistochemically stained (c). These slices are scanned and each spot, represents a different patient. Image (d) depicts a TMA
spot of clear cell renal cell carcinoma stained with MIB-1 (Ki-67) antigen. (e) shows details of the same spot containing stained and non-stained
nuclei of normal as well as abnormal cells.
in a simple and efficient manner. Figure 3 depicts the
graphical user interfaces of the three applications.
Nuclei Detection: The most tedious labeling task
is the detection of cell nuclei. In this experiment two
experts on renal cell carcinoma exhaustively labeled a
quarter of each of the 9 spots from the previous exper-
iment. Overall each expert independently marked the
center, the approximate radius and the class of more
than 2000 nuclei. Again a tablet PC was used so it
was possible to split up the work into several sessions
and the experts could use the machine at their conve-
nience. The user detects nuclei by marking the location
with the pen on the tablet and indicates the diameter by
moving the pen. A circular semi-transparent polygon
is then drawn to mark the nucleus. The final step con-
sists of choosing a class for the nucleus. In this setting
it was either black for cancerous nuclei or red for nor-
mal ones. This task has to be repeated for each nucleus
on each spot. Finally it is possible to show and hide
the annotation to gain an overview over the original tis-
sue. Figure 4 depicts a quarter of one of the RCC TMA
spots together with the annotation and the inter expert
disagreement.
The average precision of one pathologist compared to
the other is 0.92 and the average recall amounts to 0.91.
These performance numbers show that even detecting
nuclei on an histological slide is by far not an easy or
undisputed task.
Nuclei Classification: The third experiment was de-
signed to evaluate the inter and intra pathologist vari-
ability for nuclei classification, i.e. determining if a
nucleus is normal/benign or abnormal/malignant. This
step crucially influences the final outcome due to the
fact that the percentage of staining is only estimated on
the subset of cancerous nuclei. In the experiment, 180
randomly selected nuclei are sequentially presented in
three different views of varying zoom stage. The query
nucleus is indicated in each view with a red cross and
the area which comprises the next zoom view is marked
with a red bounding box (cf. Figure 3). During the setup
phase the user can adjust these views to simulate his
usual workflow as good as possible. During the experi-
ment the expert has to select a class for each nucleus and
rate his confidence. Thus, he has the choice between six
buttons: tumor certainly, tumor probably, tumor maybe,
benign certainly, benign probably and benign maybe.
After classifying all nuclei, which have been classified
as tumor, are displayed again and the pathologist has to
estimate if the nucleus is stained or not. Again he has
to rate his confidence in his own decision on a scale of
three levels. To test the intra pathologist’s variability a
subset of nuclei was queried twice but the images were
flipped and rotated by 90 degree at the second display
to hamper recognition.
The results for inter-pathologist variability for the bi-
nary classification task are plotted in Figure 5a. Out
of 180 nuclei all five experts agreed on 24 nuclei to be
normal and 81 nuclei to be ab-normal, respectively can-
cerous. For the other 75 nuclei (42%) the pathologists
disagreed.
The analysis of the intra-pathologist error is shown in
Figure 5b. The overall intra classification error is 21.2%
This means that every fifth nucleus was classified by an
expert first as cancerous and the second time as normal
or vice versa. The self-assessment of confidence allows
us also to analyze single pathologists. For example Fig-
ure 5c shows the results of a very self-confident patholo-
gist who is always very certain of his decisions but ends
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(a) (b) (c) (d)
Figure 5: (a) Inter-pathologist classification variability based on 180 nuclei labeled by five domain experts. The experts agree on 105 out of
180 nuclei (blue bars: 24 normal, 81 cancerous). (b-d) Confusion matrices including reader confidence for intra-observer variability in nuclei
classification: (b) The combined result of all five experts yields a intra pathologist classification error of 21.2%. (c) Example of an extremely
self-confident pathologist with 30% error. (d) A very cautions pathologist with a misclassification error of 18%.
up with an error of 30% in the replication experiment.
Figure 5d on the other hand is the result of a very cau-
tious expert who is rather unsure of his decision, but
with a misclassification error of 18% he performs sig-
nificantly better than the previous one. The important
lesson learned is, that self-assessment is not a reliable
information to learn from. The intuitive notion, to use
only training samples which were classified with high
confidence by domain experts is not valid.
In defense of human pathologist it has to be men-
tioned that these experiments represent the most gen-
eral way to conduct a TMA analysis and analogous
studies in radiology report similar results [10, 11]. In
practice, domain experts focus only on regions of TMA
spots which are very well processed, which have no
staining artifacts or which are not blurred. The nu-
clei analyzed in this experiment were randomly sam-
pled from the whole set of detected nuclei to mimic the
same precondition which an algorithm would encounter
in routine work. Reducing the analysis to perfectly pro-
cesses regions would most probably decrease the intra-
pathologist error.
Staining Estimation: The most common task in
manual TMA analysis requires to estimate the staining.
To this end a domain expert views the spot of a patients
for several seconds and estimates the number of stained
abnormal cells without resorting to actual nuclei count-
ing. This procedure is iterated for each spot on a TMA-
slide to get an estimate for each patient in the study.
It is important to note that, due to the lack of compet-
itive algorithms, the results of nearly all TMA studies
are based on this kind of subjective estimations.
To investigate estimation consistency we presented 9
randomly selected TMA spots to 14 trained pathologists
of the University Hospital Zurich.
The estimations of the experts varied by up to 20% as
shown in Figure 6b. As depicted in Figure 6b the stan-
dard deviation between the experts grows linearly with
the average estimated amount of staining. The high vari-
ability demonstrates the subjectivity of the estimation
process. This uncertainty is especially critical for types
of cancer for which the clinician chooses the therapy
based on the estimated staining percentage. This result
not only motivates but emphasizes the need for more ob-
jective estimation procedures than current practice. Our
research is stimulated by the hope, that computational
pathology approaches do not only automated such esti-
mation processes but also produce better reproduceable
and more objective results than human judgment.
2.4. Expert Variability in Fluorescence Microscopy
Complementary to immunohistochemical TMA anal-
ysis, fluorescence microscopy is applied often for high-
throughput screening of molecular phenotypes. A com-
prehensive study evaluating the performance of domain
experts regarding the detection of lymphocytes is pre-
sented by [12]. In a best case, a medium-skilled ex-
pert needs on average one hour for analyzing a fluores-
cence micrograph. Each micrograph contains between
100 and 400 cells and is of size 658 × 517 pixel. Four
exemplary micrographs were blindly evaluated by five
experts. To evaluate the inter-observer variability nat-
tkemper et al. [12] define a gold standard comprising
all cell positions in a micrograph that were detected by
at least two experts.
Averaged over of CD3, CD4, CD7 and CD8 the sen-
sitivity of the four biomedical experts is varying be-
tween 67.5% and 91.2% and the positive predictive
value (PPV) between 75% and 100%. Thus the average
detection error over all biomedical experts and micro-
graphs is approximately 17%. Although fluorescence
images appear to be easier to analyze due to their homo-
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(a) (b)
Figure 6: (a) Results for 4 TMA spots from the labeling experiment conducted to investigate the inter pathologist variability for estimating nuclear
staining. 14 trained pathologists estimated MIB-1 staining on 9 TMA spots. The boxplots show a large disagreement between pathologist on spots
with an averages staining of more than 10%. The absolute estimated percentage is plotted on the y-axis. Spot 1 for example, yields a standard
deviation of more than 20%. (b) The standard deviation grows linearly with the average estimated staining.
geneous background, this high detection error indicates
the difficulty of this analysis task. These results corrob-
orates the findings in the ccRCC detection experiment
described in Section 2.1.
2.5. Generating a Gold Standard
The main benefit of labeling experiments like the
ones described before, is not to point out the high inter
and intra variability between pathologists, but to gener-
ate a gold standard. In absence of an objective ground
truth measurement process, a gold standard is crucial for
the use of statistical learning, first for learning a classi-
fier or regressor and second for validating the statistical
model.
Section 5 shows an example how the information
gathered in the experiments of Section 2.3 can be used
to train a computational pathology system.
Besides labeling application which are developed for
specific scenarios as the one described in Section 2.3
several other possibilities exist to acquire data in pathol-
ogy in a structured manner. Although software for tablet
PCs is the most convenient approach to gather informa-
tion directly in the hospital it is limited by the low num-
ber of test subjects which can complete an experiment.
To overcome this limitation the number of labelers can
be extended significantly by the use of web-based tech-
nologies.
Crowd-sourcing services like Amazon Mechanical
Turk can be used to gather large numbers of labels
at a low cost. Applications in pathology suffer from
the main problem, that the labelers are all non-experts.
While crowd-sourcing works well for task based on nat-
ural images [13], it poses a considerable problems in
pathology where for example the decision if a nucleus
is normal or cancerous is based on complicated crite-
ria [14] which require medical training and knowledge.
Likewise the recognition of some supercellular morpho-
logical structures requires years of training and supervi-
sion. Nevertheless crowd-sourcing could be useful in
simple detection tasks like finding nuclei in histological
slides.
2.6. Multiple Expert Learning
In classical supervised learning, a set of training data
{(xi, yi)}i=1,...,n is available which consists of objects xi
and their corresponding labels yi. The task is to predict
the label y for a new test object x. This approach is valid
as long as the target variable Y = {y1, . . . , yn} denotes
the ground truth of the application. If this condition is
met, Y and X = {x1, . . . , xn} can be used for classifier
learning and evaluation.
Unfortunately, for a large number of real word appli-
cation ground truth is either not available or very expen-
sive to acquire. In practice, as a last resort, one would
ask several domain experts for their opinion about each
object xi in question to generate a gold standard as de-
scribed in Section 2.5. Depending on the difficulty of
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(a) (b)
(c) (d)
Figure 4: (a) A quarter of an RCC TMA spot used for the nuclei detec-
tion experiment. (b) Annotations of one expert, indicating abnormal
nuclei in black and normal ones in red. (c) Overlay of detected nuclei
from expert one (blue circles) and expert two (red crosses). (d) Dis-
agreement between the two domain experts regarding the detection
task. Nuclei which were labeled only by pathologist one are shown in
blue and the nuclei found only by expert two are depicted in red.
the task and the experience of the experts this question-
ing often results in an ambiguous labeling due to dis-
agreement between experts. In pathology, very chal-
lenging scenarios, like assessing the malignancy of a
cell, not only the inter, but also the intra expert variabil-
ity is quite large (cf. Section 2.3). Moreover, restricting
the dataset to the subset of consistently labeled samples
results in loss of the majority of data in these scenarios.
Consequently, such a data acquisition procedure
poses a fundamental problem for supervised learning.
Especially in computational pathology there is clearly a
need for novel algorithms to address the labeling prob-
lem and to provide methods to validate models under
such circumstances.
More formally, each yi is replaced by a D dimensional
vector y¯i = {y1i , . . . , yDi }, where ydi represents the i-th la-
bel of domain expert d. To this end one is interested
in learning a classifier Φ(X, Y¯) from the design matrix
X and the labeling matrix Y¯ . To date it is an open re-
search question, how such classifier Φ(X, Y¯) should be
formulated.
Recently [15, 16] presented promising results based
on expectation maximization where the hidden ground
(a)
(b)
Figure 7: Labeling matrix with majority vote (a) and confidence ma-
trix with confidence average (b) of five domain experts classifying 180
ccRCC nuclei into cancerous (red) and benign (green).
truth is estimated in turn with the confidence in the ex-
perts. Also along this lines [17] introduced a probabilis-
tic model to simultaneously infer the label of images,
the expertise of each labeler, and the difficulty of each
image. An application for diabetes especially for detect-
ing hard exudates in eye fundus images was published
by [18].
Although a number of theoretical results exist [19,
20, 21], empirical evidence is still lacking to establish
that these approaches are able to improve over simple
majority voting [22, 23] in real world applications.
A further, promising line of research investigates the
question if such a classifier Φ(X, Y¯) can be learned in an
on-line fashion, especially when the new labels come
from a different domain expert. An affirmative answer
would show a high impact in domains where specific
models can be trained for years by a large number of
experts, e.g. medical decision support.
In summary, extending supervised learning to han-
dle domain expert variability is an exciting challenge
and promises direct impact on applications not only
in pathology but in a variety of computer vision tasks
where generating a gold standard poses a highly non
trivial challenge.
2.7. Public Datasets with Labeling Information
The available of public datasets with labeling infor-
mation is crucial for the advance of an empirical sci-
ence. Although a comprehensive archive like the UCI
machine learning repository [24] does not exist for com-
putational pathology, there are a number of datasets and
initiatives which disseminate various kinds of data.
Immunohistochemistry: The most comprehensive
database for antibodies and human tissue is by far the
Human Protein Atlas [25, 26]. Comprising spots from
tissue micro arrays of 45 normal human tissue types, it
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contains anywhere from 0−6 images for each protein in
each tissue type. The images are roughly 3000 × 3000
pixels in size, with each pixel approximately represent-
ing a 0.5 × 0.5µm region on the microscopy slide.
A segmentation benchmark for various tissue types
in bioimaging was compiled by [27], including 58
histopathological H&E stained images of breast cancer.
The dataset provides labels from a single expert for the
tasks of segmentation and cell counting.
Cytology: Automation in cytology is the oldest and
most advanced branch in the field of image processing
in pathology. Reason therefore are that digital imag-
ing is rather straightforward and that single cells on a
homogeneous background are more easily detected and
segmented than in tissue. As a result commercial so-
lutions are available since decades. Nevertheless espe-
cially the classification of detected and segmented nu-
clei still poses large difficulties for computational ap-
proaches. [28] published ten color microscopic images
from serous cytology with hand segmentation labels.
For bronchial cytology [29] provide eight color mi-
croscopic images. Ground truth information for three
classes (nucleus, cytoplasm, and background pixels) is
also available for each image. Pixels have a label spec-
ifying their classes (2: nucleus, 1: cytoplasm, 0: back-
ground).
A dataset of 3900 cells has been extracted from micro-
scopical image (serous cytology) by [30]. This database
has been classified into 18 cellular categories by experts.
Fluorescence Microscopy: A hand-segmented set of
97 fluorescence microscopy images with a total of 4009
cells has been published by [31]. For fluorescence mi-
croscopy, the simulation of cell population images is an
interesting addition to validation with manual labels of
domain experts. [12, 32] present simulation frameworks
for synthetically generated cell population images. The
advantage of these techniques is the possibility to con-
trol parameters like cell density, illumination and the
probability of cells clustering together. [32] supports
also the simulation of various cell textures and different
error sources. The obvious disadvantage are (i) that the
model can only simulate what it knows and therefore
can not represent the whole variability of biological cell
images and (ii) that these methods can only simulate cell
cultures without morphological structure. The later dis-
advantage also prevents their use in tissue analysis. Al-
though the thought of simulated tissue images in light
microscopy is appealing, currently there does not exist
methods which could even remotely achieve that goal.
3. Imaging: From Classical Image Processing to
Statistical Pattern Recognition
In recent years, a shift from rule based expert system
towards learned statistical models could be observed
in medical information systems. The substantial in-
fluence that machine learning had on the computer vi-
sion community is also reflecting more and more on
medical imaging in general and histopathology in spe-
cial. Classifiers for object detection and texture descrip-
tion in conjunction with various kinds of Markov ran-
dom fields are continuously replacing traditional water-
shed based segmentation approaches and handcrafted
rule-sets. Just recently [33] successfully demonstrated
the use of pairwise Markov models for high-throughput
detection of prostate cancer in histological sections.
An excellent review of state-of-the-art histopathological
image analysis methodology was compiled by [34].
As with most cutting edge technologies, commercial
imaging solutions lag behind in development but the
same trend is evident. [35] review commercial solutions
for quantitative immunohistochemistry in the pathology
daily practice.
Despite the general trend towards probabilistic mod-
els, very classical approaches like mathematical mor-
phology [36] are still used with great success. Recently,
[37] presented a framework for segmentation based on
morphological clustering of bivariate color histograms
and [38] devised an iterative morphological algorithm
for nuclei segmentation.
Besides common computer vision tasks like object
detection, segmentation and recognition, histopatholog-
ical imaging poses domain specific problems such as es-
timating staining of nuclei conglomerates [39] and dif-
ferentiation nuclei by their shape [40].
3.1. Preprocessing vs. Algorithmic Invariance
Brightfield microscopic imaging often produces large
differences of illumination within single slides or TMA
spots. These variations are caused by the varying thick-
ness of the slide or by imperfect staining. Such prob-
lems can be overcome either by preprocessing the im-
age data or by designing and integrating invariance into
the algorithmic processing to compensate for these vari-
ations.
Inconsistencies in the preparation of histology slides
render it difficult to perform a quantitative analysis on
their results. An normalization approach based on opti-
cal density and SVD projection is proposed by [41] for
overcoming some of the known inconsistencies in the
staining process. Slides which were processed or stored
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under very different conditions are projected into a com-
mon, normalized space to enable improved quantitative
analysis.
Preprocessing and normalization methods usually not
only reduce noise induced differences between samples
but often also eliminate the biological signal of interest.
As an alternative to such an irreparable information loss
during data acquisition, algorithms with illumination in-
variance or with compensation of staining artifacts are
designed which are robust to these uncontrollable ex-
perimental variations.
Relational Detection Forests [42] provide one possi-
bility to overcome this problem of information loss. Es-
pecially designed for detection of cell nuclei in histo-
logical slides, they are based on the concept of random-
ized trees [43]. The features, which are selected for this
framework center around the idea that relation between
features are more robust than thresholds on single fea-
tures. A similar idea was applied by [44] to gene chip
analysis where similar problems occur, due to the back-
ground noise of different labs. Contrary to the absolute
values the relation between DNA expression is rather
robust.
Object detection is commonly solved by training a
classifier on patches centered at the objects of interest
[45], e.g., the cell nuclei in medical image processing
of histological slides. Considering only the relation be-
tween rectangles within these patches results in illumi-
nation invariant features which give the same response
for high and low contrast patches as long as the shape
of the object is preserved. It has to be noted, that due to
the directionality of the relation they fail if the image is
inverted. In general, illumination invariance speeds up
the whole analysis process because neither image nor-
malization nor histogram equalization are required.
The feature base proposed in [42] is defined as fol-
lows: The coordinates of two rectangles R1 and R2 are
sampled uniformly within a predefined window size w:
Ri = {cx1, cy1, cx2, cy2}, ci ∼ U(x|0,w)
For each rectangle the intensities of the underlying gray
scale image are summed up and normalized by the area
of the rectangle. The feature f (s,R1,R2) evaluates to a
boolean value by comparing these quantities:
f (s,R1,R2) =

1 if
∑
i|xi∈R1
xi
n1
<
∑
i|xi∈R2
xi
n2
0 otherwise
(1)
where xi is the gray value intensity of pixel i of sam-
ple s = {x1, x2, . . . , xn} and n1, n2 denote the number of
samples in R1,R2, respectively. From a general point of
view this definition is similar to generalized Haar fea-
tures but there are two main differences: (i) the quantity
of interest is not the continuous difference between the
rectangles but the boolean relation between them and
hence (ii) it is not necessary to learn a threshold on the
difference to binarize the feature.
For example, in the validation experiments a window
size of 65 × 65 pixels was chosen. Taking into ac-
count that rectangles are flipping invariant, this results
in
(
(644)/4
)2 ≈ 2 · 1013 possible features.
Putting this into perspective, the restriction of the detec-
tor to windows of size 24×24 leads to ∼ 6.9·109 features
which are significantly more than the 45, 396 Haar fea-
tures from classical object detection approaches [45].
For such huge feature spaces it is currently not possi-
ble to exhaustively evaluate all features while training a
classifier. Approaches like AdaBoost [46] which yield
very good results for up to hundreds of thousands of
features are not applicable any more. These problems
can be overcome by employing randomized algorithms
[42, 47] where features are sampled randomly for learn-
ing classifiers on these random projections.
3.2. Inter-Active and Online Learning for Clinical Ap-
plication
Day-to-day clinical application of computational
pathology algorithms require adaptivity to a large va-
riety of scenarios. Not only that staining protocols and
slide scanners are constantly updated and changed but
common algorithms like the quantification of prolifer-
ation factors have to work robustly on various tissue
types. The detection of multiple objects like nuclei in
noisy images without an explicit model is still one of
the most challenging tasks in computer vision. Meth-
ods which can be applied in an plug-and-play manner
are not available to date.
[48] present an inter-active ensemble learning algo-
rithm based on randomized trees, which can be em-
ployed to learn an object detector in an inter-active fash-
ion. In addition this learning method can cope with high
dimensional feature spaces in an efficient manner and in
contrast to classical approaches, subspaces are not split
based on thresholds but by learning relations between
features.
Incorporating the knowledge of domain experts into
the process of learning statistical models poses one of
the main challenges in machine learning [49] and com-
puter vision. Data analysis applications in pathology
share properties of online and active learning which can
be termed inter-active learning. The domain expert in-
terferes with the learning process by correcting falsely
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classified samples. Algorithm 9 sketches an overview
of the inter-active learning process.
In recent years online learning has been of major in-
terest to a large variety of scientific fields. From the
viewpoint of machine learning [50] summarizes a com-
prehensive overview of existing methods and open chal-
lenges. In computer vision online boosting has been
successfully applied to car detection [51], video surveil-
lance [52] and visual tracking [53]. One of the first
inter-active frameworks was developed by [54] and ap-
plied to pedestrian detection.
Ensemble methods like boosting [46] and random
forests [55, 43] celebrated success in a large variety of
tasks in statistical learning but in most cases they are
only applied offline. Lately, online ensemble learning
for boosting and bagging was investigated by [56] and
[57]. The online random forest as proposed by [58]
incrementally adopts new features. Updating decision
trees with new samples was described by [59, 60] and
extended by [61, 62]. Update schemes for pools of ex-
perts like the WINNOW and Weighted Majority Algo-
rithm were introduced by [63, 64] and successfully em-
ployed since then.
In many, not only medical domains, accurate and ro-
bust object detection specifies a crucial step in data anal-
ysis pipelines. In pathology for example, the detection
of cell nuclei on histological slides serves as the basis
for a larger number of tasks such as immunohistochem-
ical staining estimation and morphological grading. Re-
sults of medical interest such as survival prediction are
sensitively influenced by the accuracy of the object de-
tection algorithm. The diagnosis of the pathologist in
turn leads to different treatment strategies and hence di-
rectly affects the patient. For most of these medical pro-
cedures the ground truth is not known (see Section 2)
and for most problems biomedical science lacks orthog-
onal methods which could verify a considered hypothe-
ses. Therefore, the subjective opinion of the medical
doctor is the only gold standard available for training
such decision support systems.
In such scenarios the subjective influence of a single
human can be mitigated by combining the opinions of
a larger number of experts. In practice consolidating
expert judgments is a cumbersome and expensive pro-
cess and often additional experts are not available at a
given time. To overcome these problems online learn-
ing algorithms are capable of incorporating additional
knowledge, so-called side-information, when it is avail-
able.
In an ideal clinical setting, a specialized algorithm for
cell nuclei detection should be available for each sub-
type of cancer. By using and correcting the algorithm
Algorithm 1: Schematic workflow of an inter-active
ensemble learning framework. The domain expert
interacts with the algorithm to produce a classi-
fier (object detector) which satisfies the conditions
based on the experts domain knowledge.
Data: Unlabeled Instances U = {u1, . . . , un}
1 %(e.g. image) Input: Domain Expert E
Output: Ensemble Classifier C
2 while (expert is unsatisfied with current result) do
3 classify all samples ui;
4 while (expert corrects falsely predicted sample
ui with label li) do
5 update weights of the base classifiers
6 learn new base classifiers
7 end
8 end
9 return C
several domain experts as its users continuously train
and update the method. Thereby, the combined knowl-
edge of a large number of experts and repeated training
over a longer period of time yields more accurate and
more robust classifiers than batch learning techniques.
The described setting differs from the conventional
views of online learning and active learning insofar that
new samples are neither chosen at random nor proposed
for labeling by the algorithm itself. In addition, the ad-
versary is not considered malicious but also not com-
pletely trustworthy. The domain expert reacts to the
classification of unlabeled data and corrects wrongly
classified instances. These preconditions lead to the
success or failure of different combination rules.
It has to be noted, that these kind of machine learning
approaches are in sharp contrast to classical rule bases
expert systems [65] which are still used by a number of
commercial medical imaging companies. For these ap-
plications the user has to be an image processing experts
who chooses dozens of features and thresholds by hand
to create a rule set adapted to the data. Contrary to that
strategy, in an inter-active learning framework the user
has to be a domain expert, in our case a trained patholo-
gists. Feature extraction and learning of statistical mod-
els is performed by the algorithms so that the expert can
concentrate on the biomedical problem at hand. Inter-
active learning frameworks like [51, 48] show promis-
ing results, but further research especially on long term
learning and robustness is mandatory to estimate the re-
liability of these methods prior to an application in clin-
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ical practice.
3.3. Multispectral Imaging and Source Separation
Multispectral imaging [66, 67] for immunohisto-
chemically stained tissue and brightfield microscopy
seems to be a promising technology although a number
of limitations have to be kept in mind.
To date, double- or triple-staining of tissue samples
on a single slide in brightfield (non-fluorescence) mi-
croscopy poses still a major challenge. Traditionally,
double staining relied on chromogens, which have been
selected to provide maximum color contrast for obser-
vation with the unaided eye. For visually good color
combinations, however, technically feasible choices al-
ways include at least one diffuse chromogen, due to
the lack of appropriate chromogen colors. Additional
problems arise from spatial overlapping and from un-
clear mixing of colors. Currently, these problem are ad-
dressed by cutting serial sections and by staining each
one with a different antibody and a single colored label.
Unfortunately, localized information on a cell-by-cell
basis is lost with this approach. In the absence of larger
structures like glands, registration of sequential slices
proved to be highly unreliable and often not feasible at
all. Multispectral imaging yield single-cell-level mul-
tiplexed imaging of standard Immunohistochemistry in
the same cellular compartment. This technique even
works in the presence of a counterstain and each label
can be unmixed into separate channels without bleed-
through.
Computational pathology algorithms would profit
from multispectral imaging also is experiments with
single stains, due to the possibility to accurately sepa-
rate the specific label signals from the background coun-
terstain.
Practical suggestions for immunoenzyme double
staining procedures for frequently encountered antibody
combinations like rabbitmouse, goatmouse, mouse-
mouse, and rabbitrabbit are discussed in [67]. The
suggested protocols are all suitable for a classical red-
brown color combination plus blue nuclear counterstain.
Although the red and brown chromogens do not contrast
very well visually, they both show a crisp localization
and can be unmixed by spectral imaging.
Detection an segmentation of nuclei, glands or other
structures constitute a crucial steps in various compu-
tational pathology frameworks. With the use of super-
vised machine learning techniques these tasks are of-
ten performed by trained classifiers which assign labels
to single pixels. Naturally one can ask if MSI could
improve this classification process and if the additional
spectral bands contain additional information? A study
conducted by [68] set out to answer this question in the
scope of routine clinical histopathology imagery. They
compared MSI stacks with RGB imagery with the use
of several classifier ranging from linear discriminant
analysis (LDA) to support vector machines (SVM). For
H&E slide the results indicate performance differences
of less than 1% using multispectral imagery as opposed
to preprocessed RGB imagery. Using only single im-
age bands for classification showed that the single best
multispectral band (in the red portion of the spectrum)
resulted in a performance increase of 0.57%, compared
to the performance of the single best RGB band (red).
Principal components analysis (PCA) of the multispec-
tral imagery indicated only two significant image bands,
which is not surprising given the presence of two stains.
The results of [68] indicate that MSI provides mini-
mal additional spectral information than would standard
RGB imagery for routine H&E stained histopathology.
Although the results of this study are convincing it
has to be noted that only slides with two channels were
analyzed. For triple and quadruple staining as described
in [67] MSI could still encode additional information
which should lead to a higher classification perfor-
mance. Similar conclusions are drawn by [69], stating
that MSI has significant potential to improve segmenta-
tion and classification accuracy either by incorporation
of features computed across multiple wavelengths or by
the addition of spectral unmixing algorithms.
Complementary to supervised learning as described
before, [70] proposed unsupervised blind source separa-
tion for extracting the contributions of various histolog-
ical stains to the overall spectral composition through-
out a tissue sample. As a preprocessing step all images
of the multispectral stack were registered to each other
considering affine transformations. Subsequently it was
shown that Non-negative Matrix Factorization (NMF)
[71] and Independent Component Analysis (ICA) [72]
compare favorable to Color Deconvolution [73]. Along
the same lines [74] advocate principal component anal-
ysis (PCA) and blind source separation (BSS) to decom-
pose hyperspectral images into spectrally homogeneous
compounds.
In the domain of fluorescence imaging [75] give an
overview of several source separation methods. The
main difficulty stems from the significant overlap of the
emission spectra even with the use of fluorescent dyes.
To this end [76] conduct a study on more than 3500 im-
ages from the Human Protein Atlas [25, 26]. They con-
cluded that subcellular locations can be determined with
an accuracy of 87.5% by the use of support vector ma-
chines and random forests [55, 43]. Due to the spread
of Type-2 diabetes there is growing interest in pancre-
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atic islet segmentation and cell counting of α and β-cells
[77]. An approach which is based on the strategies de-
scribed in Section 3.1 and Section 3.2 is described in
[78].
It is an appealing idea to apply source separation
techniques not only to multispectral imaging but also
to standard RGB images. This approach could be useful
for a global staining estimation of the separate channels
or as a preprocessing step for training a classifier. Un-
fortunately, antigen-antibody reactions are not stoichio-
metric. Hence the intensity/darkness of a stain does not
necessarily correlate with the amount of reaction prod-
ucts. With the exception of Feulgen staining also most
histological stains are not stoichiometric. [67] also state
that the brown DAB reaction product is not a true ab-
sorber of light, but a scatterer of light, and has a very
broad, featureless spectrum. This optical behavior im-
plies that DAB does not follow the Beer-Lambert law,
which describes the linear relationship between the con-
centration of a compound and its absorbance, or op-
tical density. As a consequence, darkly stained DAB
has a different spectral shape than lightly stained DAB.
Therefore attempting to quantify DAB intensity using
source separation techniques is not advisable. Contrary
to this observation, employing a non-linear convolution
algorithm as preprocessing for a linear classifier, e.g. for
segmentation could be of benefit.
Finally, multispectral imaging is not available for au-
tomated whole slide scanning which constrains its ap-
plicability. Imaging a TMA manually with a micro-
scope and a MSI adapter is too tedious and time con-
suming.
3.4. Software Engineering Aspects
One of the earliest approaches for high performance
computing in pathology used image matching algo-
rithms based on decision trees to retrieve images from a
database [79]. The approach was applied to Gleason
grading in prostate cancer. Web-based data manage-
ment frameworks for TMAs like [80] facilitate not only
storage of image data but also storage of experimental
and production parameters throughout the TMA work-
flow.
A crucial demand on software engineering is the abil-
ity to scale automated analysis to multiple spots on a
TMA slide and even multiple whole microscopy slides.
Besides cloud computing one possibility to achieve that
goal is grid computing. [81] demonstrated the feasibil-
ity of such a system by using the caGrid infrastructure
[82] for Grid-enabled deployment of an automated can-
cer tissue segmentation algorithm for TMAs.
A comprehensive list of open source and public do-
main software for image analysis in pathology is avail-
able at www.computational-pathology.org.
4. Statistics: Survival Analysis and Machine Learn-
ing in Medical Statistics
The main thrust of research in computational pathol-
ogy is to build completely probabilistic models of the
complete processing pipelines for histological and med-
ical data. In medical research this nearly always also
includes time to event data, where the event is either
overall survival, specific survival, event free survival or
recurrence free survival of patients. Statistics and ma-
chine learning within this scope is defined as Survival
Analysis.
4.1. Censoring and Descriptive Statistics
Most difficulties in survival statistics arise from the
fact, that nearly all clinical datasets contain patients
with censored survival times. The most common form
of censoring is right censored data which means that the
death of the patient is not observer during the runtime
of the study or that the patient withdrew from the study,
e.g. because he moved to another location.
The nonparametric Kaplan-Meier estimator [83] is
frequently used to estimate the survival function from
right censored data. This procedure requires first to-
order the survival times from the smallest to the largest
such that t1 ≤ t2 ≤ t3 ≤ . . . ≤ tn, where t j is the jth
largest unique survival time. The Kaplan-Meier esti-
mate of the survival function is then obtained as
Sˆ (t) =
∏
j:t( j)≤t
(
1 − d j
r j
)
(2)
where r j is the number of individuals at risk just before
t j, and d j is the number of individuals who die at time
t j.
To measure the goodness of separation between two
or more groups, the log-rank test (Mantel-Haenszel test)
[84] is employed to assesses the null hypothesis that
there is no difference in the survival experience of the
individuals in the different groups. The test statistic of
the log-rank test (LRT) is χ2 distributed:
χˆ2 =
(∑m
i=1 (d1i − eˆ1i)
)2∑m
i=1 vˆ1i
(3)
where d1i is the number of deaths in the first group at ti
and e1i = r1 j diri where di is the total number of deaths at
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time t(i), r j is the total number of individuals at risk at
this time, and r1i the number of individuals at risk in the
first group. Figure 9 depicts Kaplan-Meier plots for two
subgroups each and the LRT p-values. The associated
data is described in detail in Section 5.
4.2. Survival Analysis
Survival Analysis as a branch of statistics is not re-
stricted to medicine but analyses time to failure or event
data and is also applicable to biology, engineering, eco-
nomics etc. Particularly in the context of medical statis-
tics, it is a powerful tool for understanding the effect
of patient features on survival patterns within specific
groups [85]. A parametric approach to such an analysis
involves the estimation of parameters of a probability
density function which models time.
In general the distribution of a random variable T
(representing time) is defined over the interval [0,∞).
Furthermore, a standard survival function is specified
based on the cumulative distribution over T as follows:
S (t) = 1 − p(T ≤ t0) = 1 −
∫ t0
0
p(t)dt, (4)
which models the probability of an individual surviving
up to time t0. The hazard function h(t), the instanta-
neous rate of failure at time t, is defined as follows:
h(t) = lim
∆t→0
P(t < T ≤ t + ∆t|T > t)
∆t
=
p(T = t)
S (t)
. (5)
The model is further extended by considering the ef-
fect of covariates X on time via a regression component.
In medical statistics the most popular method for model-
ing such effects is Cox’s proportionality hazards model
[86]:
h(t|x) = h0(t) exp(xTβ), (6)
where h0(t) is the baseline hazard function, which is the
chance of instant death given survival till time t, x is
the vector of covariates and β are the regression coeffi-
cients.
4.3. A Bayesian View of Survival Regression
Bayesian methods are gaining more and more pop-
ularity in machine learning in general and in medical
statistics in special. A big advantage in survival anal-
ysis is the possibility to investigate the posterior distri-
bution of a model. Especially in regularized survival
regression models [87] it is possible to get a posterior
distribution also on zero coefficients, i.e. for biomark-
ers which hence were not included in the model.
A common choice of distribution for modeling time
is the Weibull distribution which is flexible in terms of
being able to model a variety of survival functions and
hazard rates. Apart from flexibility, it is also the only
distribution which captures both the accelerated time
model and the proportionality hazards model [88]. The
Weibull distribution is defined as follows:
p(t|αw, λw) = αw 1
λw
tαw−1 exp
(
− 1
λw
tαw
)
, (7)
where αw and λw are the shape and scale parameters,
respectively. Based on the above definition and assum-
ing right-censored data [85], the likelihood assumes the
form
p({ti}Ni=0 |αw, λw) =
N∏
i=1
(
αw
λw
tαw−1i
)δi
exp
(
− 1
λw
tαwi
)
, (8)
where δi = 0 when the ith observation is censored and
1 otherwise. Further, to model the effect of covariates
x on the distribution over time, Cox’s proportional haz-
ards model can be applied. Under this model, the co-
variates are assumed to have a multiplicative effect on
the hazard function.
4.4. Higher Order Interactions
A reoccurring question in biomedical research
projects and especially in TMA analysis studies interac-
tions of markers and their influence on the target. Two
modern approaches within the scope of computational
pathology try to solve this question from a frequentist
[89] and a Bayesian [87] point of view.
The most frequent approach for modeling higher-
order interactions (like pairs or triplets of fea-
tures etc.) instead of modeling just the main
effects (individual features) are polynomial expan-
sions of features. For example the vector x =
{x1, x2, x3} can be expanded up to order 2 as x′ =
{x1, x2, x3, x1 : x2, x1 : x3, x2 : x3, x1 : x2 : x3}. Addi-
tional flexibility is built into this model by including a
random effect in η in the following manner:
η = xtβ + , where  ∼ N(0, σ2). (9)
To include the covariate effect the likelihood of Equa-
tion 8 is modified as follows:
p({ti}Ni=0 |xi, αw, λw) =
N∏
i=1
[
αw
λw
tαw−1i exp(ηi)
]δi
·
˙exp
(
− 1
λw
tαwi exp(ηi)
)
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These kind of models can be seen as enhancement of
generalized linear models [90] and are called random-
intercept models. For a full Bayesian treatment of the
model, suitable priors have to be defined for the param-
eters of the model, namely αw, λw, σ and β. Useful
priors for this model are described in [87].
4.5. Mixtures of Survival Experts
Frequently, sub-groups of patients specified by char-
acteristic survival times have to be identified together
with the effects of covariates within each sub-group.
Such information might hint at the disease mechanisms.
Statistically this grouping is represented by a mixture
model or specifically by a mixture of survival experts.
To this end, [91] define a finite mixture-of-experts
model by maximizing the partial likelihood for the re-
gression coefficients and by using some heuristics to
resolve the number of experts in the model. More re-
cently [92] use a maximum likelihood approach to infer
the parameters of the model and the Akaike informa-
tion criterion (AIC) to determine the number of mixture
components.
A Bayesian version of the mixture model [93] ana-
lyzes the model with respect to time but does not capture
the effect of covariates. On the other hand the work by
[94] performs variable selection based on the covariates
but ignores the clustering aspect of the modeling. Simi-
larly, [95] defines an infinite mixture model but does not
include a mixture of experts, hence implicitly assuming
that all the covariates are generated by the same distri-
bution with a common shape parameter for the Weibull
distribution.
[87] unify the various important elements of this anal-
ysis into a Bayesian mixture-of-experts (MOE) frame-
work to model survival time, while capturing the effect
of covariates and also dealing with an unknown number
of mixing components. To infer the number of experts a
Dirichlet process prior on the mixing proportions is ap-
plied, which solves the issue of determining the number
of mixture components beforehand [96]. Due to the lack
of fixed-length sufficient statistics, the Weibull distribu-
tion is not part of the exponential family of distributions
and hence the regression component, introduced via the
proportionality hazards model, is non-standard. Fur-
thermore, the framework of [87] includes sparsity con-
straints to the regression coefficients in order to deter-
mine the key explanatory factors (biomarkers) for each
mixture component. Sparseness is achieved by utilizing
a Bayesian version of the Group-Lasso [97, 98] which
is a sparse constraint for grouped coefficients [99].
5. The Computational Pathology Pipeline: A holis-
tic View
This chapter describes an genuine computational
pathology project, which has been designed following
the principles described in the previous sections. It is an
ongoing project in kidney cancer research conducted at
the University Hospital Zurich and ETH Zurich. Parts
of it were published in [100] and [42], where also al-
gorithmic details of the computational approach can be
found.
Figure 8 depicts a schematic overview of the project
subdivided into the three main parts which are discussed
in the following:
5.1. Data Generation
The data generation process consists of acquiring im-
ages of the TMA spots representing the covariates X
in the statistical model and the target variable Y which
comprises detection and classification labels for nuclei.
The tissue microarray block was generated in a trial
at the University Hospital Zurich. TMA slides were im-
munohistochemically stained with the MIB-1 (Ki-67)
antigen and scanned on a Nanozoomer C9600 virtual
slide light microscope scanner from HAMAMATSU.
The magnification of 40× resulted in a per pixel reso-
lution of 0.23µm. The tissue microarry was tiled into
single spots of size 3000 × 3000 pixel, representing one
patient each.
Various strategies can be devised to estimate the pro-
gression status of cancerous tissue: (i) we could first
detect cell nuclei and then classify the detected nuclei
as cancerous or benign [38]; (ii) the nucleus detection
phase could be merged with the malignant/benign clas-
sification to simultaneously train a sliding window de-
tector for cancerous nuclei only. To this end samples
of cancerous nuclei were collected using the labeling
experiments described in Section 2.3. Voronoi Sam-
pling [42] was used to generate a set of negative back-
ground patches which are spatially well distributed in
the training images. Hence a Voronoi tessellation is
created based on the locations of the positive samples
and background patches are sampled at the vertices of
the Voronoi diagram. In contrast to uniform rejection
sampling, using a tessellation has the advantage that the
negative samples are concentrated on the area of tis-
sue close to the nulei and few samples are spent on the
homogeneous background. (The algorithm should not
be confused with Lloyd’s algorithm [101] which is also
known as Voronoi iteration.) The result of the data gen-
eration process is a labeled set of image patches of size
65 × 65 pixel.
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Figure 8: A computational pathology framework for investigating the proliferation marker MIB-1 in clear cell renal cell carcinoma. Following the
definition in Section 1.1 the framework consists of three parts: (i) The covariate data X existing of images of TMA spots was generated in a trial at
the University Hospital Zurich. Extensive labeling experiments were conducted to generate a gold standard comprising cancerous cell nuclei and
background samples. (ii) Image analysis consisted of learning a relational detection forest (RDF) and conducting mean shift clustering for nuclei
detection. Subsequently, the staining of detected nuclei was determined based on their color histograms. (iii) Using this system, TMA spots of 133
RCC patients were analysed. Finnaly, the subgroup of patients with high expression of the proliferation marker was compared to the group with
low expression using the Kaplen-Meier estimator.
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5.2. Image Analysis
The image analysis part of the pipeline consists of
learning a relational detection forest [42] based on the
samples extracted in the previous step. To guarantee
illumination invariance, the feature basis described in
Section 3.1 is used.
The strong class imbalance in the training set is ac-
counted for by randomly subsampling the background
class for each tree of the ensemble. The model param-
eters are adjusted by optimizing the out of bag (OOB)
error [43] and they consist of the number of trees, the
maximum tree depth and the number of features sam-
pled at each node in a tree.
For prediction each pixel of a TMA spot is classified
by the relation detection forest. This results in a proba-
bility map in the size of the image where the gray value
at each position indicates the probability of being the lo-
cation of a cancerous nucleus. Finally, weighted mean
shift clustering is conducted with a circular box kernel
based on the average radius r of the nuclei in the train-
ing set. This process yields the final coordinates of the
detected cancerous nuclei.
To differentiate a stained nucleus from a non-stained
nucleus a simple color model is learned. Based on the
labeled nuclei, color histograms are generated for both
classes based on the pixels within a radius r. A test
nucleus is then classified based on the distance to the
centroid histograms of both classes.
The final staining estimation per patient is achieved
by calculating the percentage of stained cancerous nu-
clei.
5.3. Survival Statistics
The only objective endpoint in the majority of TMA
studies is the prediction of the number of months a pa-
tient survived. The experiments described in Section
2.3 document the large disagreement between patholo-
gists for the estimation of staining. Hence, fitting an
algorithm to the estimates of a single pathologist or to
a consensus voting of a commitee of pathologist is not
desirable.
To this end the proposed computational pathology
framework is validated against the right censored clin-
ical survival data of the 133 ccRCC patients. In ad-
dition these results were compared to the estimations
of an expert pathologist specialized on renal cell carci-
noma. He analyzed all spots in an exceptional thorough
manner which required him more than two hours. This
time consuming annotation exceeds the standard clin-
ical practice significantly by a factor of 10 − 20 and,
therefore, the results can be viewed as an excellent hu-
man estimate for this dataset.
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Figure 9: Kaplan-Meier estimators show significantly different sur-
vival times for renal cell carcinoma patients with high and low prolif-
erating tumors. Compared to the manual estimation from the patholo-
gist (a) (p = 0.04), the fully automatic estimation from the algorithm
(b) compares favorable (p = 0.01) in terms of survival differences (log
rank test) for the partitioning of patients into two groups of equal size
[42].
Figure 9 shows Kaplan-Meier plots of the estimated
cumulative survival for the pathologist and the com-
putational pathology framework. The farther the sur-
vival estimates of the two groups are separated the bet-
ter the estimation. Quantifying this difference with a
log-rank test shows that the proposed framework per-
forms favorable (p = 0.0113) to the trained pathologist
(p = 0.0423) and it can differentiate between the sur-
vival expectancy of the two groups of patients.
5.4. Project Conclusion
The presented computational pathology framework
can be characterized by the following properties: (i)
Simplicity: It can be used in a plug-and-play fashion
to train object detectors in near real time for large va-
riety of tasks. (ii) Novel Feature Basis: The intro-
duced relational features are able to capture shape in-
formation, they are illumination invariant and extremely
fast to evaluate. (iii) Randomization: The randomized
tree induction algorithm is able to exploit the richness
of the intractable large feature space and to take advan-
tage of it by increasing diversity of the ensemble. (iv)
Real World Applicability: The proposed algorithms
perform well not only on renal cancer tissue but also
in fluorescent imaging of pancreatic islets [78] and in
quantifying staining in murine samples [102].
6. Future Directions
6.1. Histopathological Imaging
One promising research direction in medical im-
age analysis points to online learning and interactive
learning of computer vision models. Not only covers
histopathology a broad and heterogeneous field but new
16 Preprint, June 29, 2010
A revised version of this manuscript was published in CMIG (PMID: 18982583). Please cite the final version:
“Computational Pathology: Challenges and Promises for Tissue Analysis”, Thomas J. Fuchs and Joachim M.
Buhmann, Computerized Medical Imaging and Graphics, Volume 35, Issue 7, 515–530, 2011.
biomarkers, antibodies and stainings are developed on
a daily basis. To this end, real world applications have
to quickly adapt to changing tissue types and staining
modalities. Domain experts should be able to train these
models in an interactive fashion to accustom novel data.
For example, a classifier for object detection can be
trained by clicking on novel objects or correcting for
false detections.
A necessary prerequisite for research in computa-
tional pathology proved to be the scanning of whole
slides and TMAs. [103] describe a fully digital pathol-
ogy slide archive which has been assembled by high-
volume tissue slide scanning. The Peta bytes of his-
tological data which will be available in the near fu-
ture pose also a number of software engineering chal-
lenges, including distributed processing of whole slides
and TMAs in clusters or the cloud, multiprocessor and
multicore implementations of analysis algorithms and
facilitating real time image processing on GPUs.
6.2. Clinical Application and Decision Support
In today’s patient care we observe the interesting
trend to integrate pathological diagnoses in web based
patient files. Avatar based visualization proved to be
useful not only for medical experts but also for a new
generation of patients who are better informed and de-
mand online updated and appropriately visualized in-
formations about their own disease state and treatment
procedures.
Furthermore this approach can be extended for de-
cision support by statistical models which are able to
utilize this unified view of patients incorporating data
from a large variety of clinical sources, e.g. pathology,
cytology, radiology, etc.
6.3. Pathology@home
Real-time, in vivo cancer detection on cellular level
appears as a futuristic dream in patient care but could be
a reality in a few years. [104] constructed a fiber-optic
fluorescence microscope using a consumer-grade cam-
era for in vivo cellular imaging. The fiber-optic fluores-
cence microscope includes an LED light, an objective
lens, a fiber-optic bundle, and a consumer-grade DSLR.
The system was used to image an oral cancer cell line, a
human tissue specimen and the oral mucosa of a healthy
human subject in vivo, following topical application of
0.01% proflavine. The fiber-optic microscope resolved
individual nuclei in all specimens and tissues imaged.
This capability allowed qualitative and quantitative dif-
ferences between normal and precancerous or cancerous
tissues to be identified. In combination with a compu-
tational pathology framework, this technique would al-
low the real time classification of cancerous cells in ep-
ithelial tissues. Such a portable and inexpensive system
is especially interesting for patient care in low-resource
settings like the developing world.
Constructing a microscope for mobile phones defines
the future of patient care in remote sites with centralized
analysis support. [105] built a mobile phone-mounted
light microscope and demonstrated its potential for clin-
ical use by imaging sickle and P. falciparum-infected red
blood cells in brightfield and M. tuberculosis-infected
sputum samples in fluorescence with LED excitation.
In all cases the resolution exceeded the critical level
that is necessary to detect blood cell and microorganism
morphology. This concept could provide an interesting
tool for disease diagnosis and screening, especially in
the developing world and rural areas where laboratory
facilities are scarce but mobile phone infrastructure is
available.
6.4. Standards and Exchange Formats
One of the major obstacles for wide spread use of
computational pathology is the absence of generally
agreed upon standards and exchange formats. This
deficit not only handicaps slide processing management
and whole slide digital imaging [106], but it also ex-
tends to statistical models and analysis software. Stan-
dardized exchange formats would support project spe-
cific combinations of object detectors, staining estima-
tion algorithms and medical statistics. It would be very
much desirable if at least the research community would
agree on a few simple interfaces for data and model ex-
change.
6.5. Further Reading
All links and references presented in this review
together with software, statistical models and a blog
about the topic are available from www.computational-
pathology.org.
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